Questcor to Present at BMO Capital Markets Focus on Healthcare 2006 Investor Conference.UNION CITY, Calif. -- James L. Fares, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Questcor Pharmaceuticals, Inc. (AMEX AMEX See: American Stock Exchange :QSC), will give a company update at the BMO Capital Markets Focus on Healthcare 2006 Investor Conference. The conference will be held at the Millennium Broadway Hotel, 145 West 44th Street in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Mr. Fares will make his presentation on Thursday, December 7 at 8:45 am EST EST electroshock therapy. EST abbr. electroshock therapy . The presentation will be webcast and is accessible at the following link, http://www.bmocm.com/conferences/healthcare2006 or by visiting Questcor's website, where the presentation will be archived for up to two weeks following the event, at www.questcor.com. About Questcor -- Questcor Pharmaceuticals, Inc.([R]) (AMEX:QSC) is a specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurological disorders. Questcor currently markets H.P. Acthar([R]) Gel (repository corticotropin corticotropin (kôr'təkōtrōp`ən): see adrenocorticotropic hormone. injection), an injectable drug indicated for the treatment of exacerbations associated with multiple sclerosis and Doral([R]) (quazepam), that is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. For more information, please visit www.questcor.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion